SC
OKUR

Shay Capital’s OnKure Therapeutics OKUR Stock Holding History

Shay Capital’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$547K Sell
132,219
-648,642
-83% -$2M 0.05% 257
2025
Q4 		$2.26M Sell
780,861
-137,073
-15% -$410K 0.23% 105
2025
Q3 		$2.52M Buy
917,934
+135,888
+17% +$337K 0.22% 95
2025
Q2 		$1.87M Buy
782,046
+631,008
+418% +$1.65M 0.21% 76
2025
Q1 		$649K Buy
151,038
+136,022
+906% +$765K 0.09% 121
2024
Q4 		$129K Buy
15,016
+12,154
+425% +$184K 0.02% 268
2024
Q3 		$48.6K Buy
+2,862
New +$42.3K 0.01% 291

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Shay Capital's OKUR Position: Q1 2026 in Review

Shay Capital reduced its OnKure Therapeutics (OKUR) stake by 83% in Q1 2026, selling an estimated $2M and leaving 132,219 shares worth $547K. The position accounts for 0.05% of the portfolio, ranked #257.

Shay Capital first reported a position in OKUR in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.52M in Q3 2025. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Shay Capital held 132,219 shares of OnKure Therapeutics worth $547K as of Q1 2026.
  • Shay Capital sold 648,642 OnKure Therapeutics shares in Q1 2026, an estimated $2M.
  • OnKure Therapeutics made up 0.05% of Shay Capital's portfolio in Q1 2026, its #257 holding.
  • Shay Capital first reported a position in OnKure Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Shay Capital's OnKure Therapeutics position peaked at $2.52M in Q3 2025.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.